Regulation of protein degradation by O-GlcNAcylation: Crosstalk with ubiquitination

Molecular and Cellular Proteomics

Volumn 12, Issue 12, 2013, Pages 3489-3497

  Ruan, Hai Bin ^a   Nie, Yongzhan ^b   Yang, Xiaoyong ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAMP RESPONSE ELEMENT BINDING PROTEIN TRANSCRIPTION COACTIVATOR 2; CASEIN KINASE II; CASEIN KINASE II ALPHA; COP9 SIGNALOSOME; CRYPTOCHROME 1; CRYPTOCHROME 2; CYCLIC AMP BINDING PROTEIN; CYTOKERATIN 18; CYTOKERATIN 8; ESTROGEN RECEPTOR BETA; FORSKOLIN; HISTONE; LACTOFERRIN; N ACETYLGLUCOSAMINE; PER1 PROTEIN; PER2 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR CLOCK; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SNAIL1; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN A20;

ACETYLATION; AMINOACYLATION; APOPTOSIS; CANCER CELL; CELL STRAIN MCF 7; CIRCADIAN RHYTHM; COMPLEX FORMATION; DEGENERATIVE DISEASE; ENZYME ACTIVE SITE; HUMAN; METABOLIC SYNDROME X; MOLECULAR DYNAMICS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEOMICS; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; UBIQUITINATION;

ACETYLGLUCOSAMINE; ACYLATION; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE ANNOTATION; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UBIQUITINATION; UBIQUITINS;

EID: 84890731711     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.R113.029751     Document Type: Review

References (97)

1. Goldstein, G., Scheid, M., Hammerling, U., Schlesinger, D. H., Niall, H. D., and Boyse, E. A. (1975) Isolation of a polypeptide that has lymphocytedifferentiating properties and is probably represented universally in living cells. Proc. Natl. Acad. Sci. U.S.A. 72, 11-15
2. Kimura, Y., and Tanaka, K. (2010) Regulatory mechanisms involved in the control of ubiquitin homeostasis. J Biochem. 147, 793-798
3. Hershko, A., and Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479
4. Ikeda, F., and Dikic, I. (2008) Atypical ubiquitin chains: new molecular signals. EMBO Rep. 9, 536-542
5. Hicke, L. (2001) Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol. 2, 195-201
6. Hunter, T. (2007) The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 28, 730-738
7. Gao, M., and Karin, M. (2005) Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli. Mol. Cell 19, 581-593
8. Caron, C., Boyault, C., and Khochbin, S. (2005) Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability. Bioessays 27, 408-415
9. Shukla, A., Chaurasia, P., and Bhaumik, S. R. (2009) Histone methylation and ubiquitination with their cross-talk and roles in gene expression and stability. Cell. Mol. Life Sci. 66, 1419-1433
10. Hart, G. W., Slawson, C., Ramirez-Correa, G., and Lagerlof, O. (2011) Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 80, 825-858
11. Hanover, J. A., Krause, M. W., and Love, D. C. (2012) Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol. 13, 312-321
12. Wells, L., Vosseller, K., and Hart, G. W. (2003) A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cell. Mol. Life Sci. 60, 222-228
13. Ruan, H. B., Han, X., Li, M. D., Singh, J. P., Qian, K., Azarhoush, S., Zhao, L., Bennett, A. M., Samuel, V. T., Wu, J., Yates, J. R., 3rd, and Yang, X. (2012) O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1alpha stability. Cell Metab. 16, 226-237
14. Yang, X., Su, K., Roos, M. D., Chang, Q., Paterson, A. J., and Kudlow, J. E. (2001) O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. U.S.A. 98, 6611-6616
15. Yang, X., Zhang, F., and Kudlow, J. E. (2002) Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein OGlcNAcylation to transcriptional repression. Cell 110, 69-80
16. Yang, X., Ongusaha, P. P., Miles, P. D., Havstad, J. C., Zhang, F., So, W. V., Kudlow, J. E., Michell, R. H., Olefsky, J. M., Field, S. J., and Evans, R. M. (2008) Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451, 964-969
17. Torres, C. R., and Hart, G. W. (1984) Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259, 3308-3317
18. Sakabe, K., and Hart, G. W. (2010) O-GlcNAc transferase regulates mitotic chromatin dynamics. J. Biol. Chem. 285, 34460-34468
19. Allison, D. F., Wamsley, J. J., Kumar, M., Li, D., Gray, L. G., Hart, G. W., Jones, D. R., and Mayo, M. W. (2012) Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-kappaB acetylation and transcription. Proc. Natl. Acad. Sci. U.S.A. 109, 16888-16893
20. Fujiki, R., Chikanishi, T., Hashiba, W., Ito, H., Takada, I., Roeder, R. G., Kitagawa, H., and Kato, S. (2009) GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis. Nature 459, 455-459
21. Deplus, R., Delatte, B., Schwinn, M. K., Defrance, M., Mendez, J., Murphy, N., Dawson, M. A., Volkmar, M., Putmans, P., Calonne, E., Shih, A. H., Levine, R. L., Bernard, O., Mercher, T., Solary, E., Urh, M., Daniels, D. L., and Fuks, F. (2013) TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J. 32, 645-655
22. Vousden, K. H. (2000) p53: death star. Cell 103, 691-694
23. Kruse, J. P., and Gu, W. (2008) SnapShot: p53 posttranslational modifications. Cell 133, 930-30.e1
24. Yang, W. H., Kim, J. E., Nam, H. W., Ju, J. W., Kim, H. S., Kim, Y. S., and Cho, J. W. (2006) Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 8, 1074-1083
25. Mariller, C., Hardiville, S., Hoedt, E., Huvent, I., Pina-Canseco, S., and Pierce, A. (2012) Delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor. Biochem. Cell Biol. 90, 307-319
26. Mariller, C., Hardiville, S., Hoedt, E., Benaissa, M., Mazurier, J., and Pierce, A. (2009) Proteomic approach to the identification of novel delta-lactoferrin target genes: characterization of DcpS, an mRNA scavenger decapping enzyme. Biochimie (Paris) 91, 109-122
27. Hardiville, S., Hoedt, E., Mariller, C., Benaissa, M., and Pierce, A. (2010) O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of delta-lactoferrin. J. Biol. Chem. 285, 19205-19218
28. Lee, J. M., Dedhar, S., Kalluri, R., and Thompson, E. W. (2006) The epithelial- mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172, 973-981
29. Xu, Y., Lee, S. H., Kim, H. S., Kim, N. H., Piao, S., Park, S. H., Jung, Y. S., Yook, J. I., Park, B. J., and Ha, N. C. (2010) Role of CK1 in GSK3betamediated phosphorylation and degradation of snail. Oncogene 29, 3124-3133
30. Park, S. Y., Kim, H. S., Kim, N. H., Ji, S., Cha, S. Y., Kang, J. G., Ota, I., Shimada, K., Konishi, N., Nam, H. W., Hong, S. W., Yang, W. H., Roth, J., Yook, J. I., and Cho, J. W. (2010) Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition. EMBO J. 29, 3787-3796
31. Harris, H. A. (2007) Estrogen receptor-beta: recent lessons from in vivo studies. Mol. Endocrinol. 21, 1-13
32. Cheng, X., and Hart, G. W. (2001) Alternative O-glycosylation/O- phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. J. Biol. Chem. 276, 10570-10575
33. St-Denis, N. A., and Litchfield, D. W. (2009) Protein kinase CK2 in health and disease: from birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell. Mol. Life Sci. 66, 1817-1829
34. Tarrant, M. K., Rho, H. S., Xie, Z., Jiang, Y. L., Gross, C., Culhane, J. C., Yan, G., Qian, J., Ichikawa, Y., Matsuoka, T., Zachara, N., Etzkorn, F. A., Hart, G. W., Jeong, J. S., Blackshaw, S., Zhu, H., and Cole, P. A. (2012) Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis. Nat. Chem. Biol. 8, 262-269
35. Koo, S. H., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., Takemori, H., and Montminy, M. (2005) The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109-1111
36. Dentin, R., Liu, Y., Koo, S. H., Hedrick, S., Vargas, T., Heredia, J., Yates, J., 3rd, and Montminy, M. (2007) Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 449, 366-369
37. Dentin, R., Hedrick, S., Xie, J., Yates, J., 3rd, and Montminy, M. (2008) Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319, 1402-1405
38. Fernandez-Marcos, P. J., and Auwerx, J. (2011) Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am. J. Clin. Nutr. 93, 884S-890S
39. Misaghi, S., Ottosen, S., Izrael-Tomasevic, A., Arnott, D., Lamkanfi, M., Lee, J., Liu, J., O'Rourke, K., Dixit, V. M., and Wilson, A. C. (2009) Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol. Cell. Biol. 29, 2181-2192
40. Machida, Y. J., Machida, Y., Vashisht, A. A., Wohlschlegel, J. A., and Dutta, A. (2009) The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J. Biol. Chem. 284, 34179-34188
41. Bass, J. (2012) Circadian topology of metabolism. Nature 491, 348-356
42. Ko, C. H., and Takahashi, J. S. (2006) Molecular components of the mammalian circadian clock. Hum. Mol. Genet. 15 Spec No 2, R271-R277
43. Bass, J., and Takahashi, J. S. (2010) Circadian integration of metabolism and energetics. Science 330, 1349-1354
44. Kim, E. Y., Jeong, E. H., Park, S., Jeong, H. J., Edery, I., and Cho, J. W. (2012) A role for O-GlcNAcylation in setting circadian clock speed. Genes Dev. 26, 490-502
45. Ma, Y. T., Luo, H., Guan, W. J., Zhang, H., Chen, C., Wang, Z., and Li, J. D. (2013) O-GlcNAcylation of BMAL1 regulates circadian rhythms in NIH3T3 fibroblasts. Biochem. Biophys. Res. Commun. 431, 382-387
46. Li, M. D., Ruan, H. B., Hughes, M. E., Lee, J. S., Singh, J. P., Jones, S. P., Nitabach, M. N., and Yang, X. (2013) O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination. Cell Metab. 17, 303-310
47. Kaasik, K., Kivimae, S., Allen, J. J., Chalkley, R. J., Huang, Y., Baer, K., Kissel, H., Burlingame, A. L., Shokat, K. M., Ptacek, L. J., and Fu, Y. H. (2013) Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock. Cell Metab. 17, 291-302
48. Postic, C., Dentin, R., Denechaud, P. D., and Girard, J. (2007) ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annu. Rev. Nutr. 27, 179-192
49. Guinez, C., Filhoulaud, G., Rayah-Benhamed, F., Marmier, S., Dubuquoy, C., Dentin, R., Moldes, M., Burnol, A. F., Yang, X., Lefebvre, T., Girard, J., and Postic, C. (2011) O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 60, 1399-1413
50. Ido-Kitamura, Y., Sasaki, T., Kobayashi, M., Kim, H. J., Lee, Y. S., Kikuchi, O., Yokota-Hashimoto, H., Iizuka, K., Accili, D., and Kitamura, T. (2012) Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation. PLoS One 7, e47231
51. Kim, S., and Coulombe, P. A. (2007) Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev. 21, 1581-1597
52. Omary, M. B., Ku, N. O., Tao, G. Z., Toivola, D. M., and Liao, J. (2006) "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem. Sci. 31, 383-394
53. Srikanth, B., Vaidya, M. M., and Kalraiya, R. D. (2010) O-GlcNAcylation determines the solubility, filament organization, and stability of keratins 8 and 18. J. Biol. Chem. 285, 34062-34071
54. Shrikhande, G. V., Scali, S. T., da Silva, C. G., Damrauer, S. M., Csizmadia, E., Putheti, P., Matthey, M., Arjoon, R., Patel, R., Siracuse, J. J., Maccariello, E. R., Andersen, N. D., Monahan, T., Peterson, C., Essayagh, S., Studer, P., Guedes, R. P., Kocher, O., Usheva, A., Veves, A., Kaczmarek, E., and Ferran, C. (2010) O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS One 5, e14240
55. Olivier-Van Stichelen, S., Guinez, C., Mir, A. M., Perez-Cervera, Y., Liu, C., Michalski, J. C., and Lefebvre, T. (2012) The hexosamine biosynthetic pathway and O-GlcNAcylation drive the expression of beta-catenin and cell proliferation. Am. J. Physiol. Endocrinol. Metab. 302, E417-E424
56. Datta, R., Choudhury, P., Ghosh, A., and Datta, B. (2003) A glycosylation site, 60SGTS63, of p67 is required for its ability to regulate the phosphorylation and activity of eukaryotic initiation factor 2alpha. Biochemistry 42, 5453-5460
57. Caldwell, S. A., Jackson, S. R., Shahriari, K. S., Lynch, T. P., Sethi, G., Walker, S., Vosseller, K., and Reginato, M. J. (2010) Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29, 2831-2842
58. Hu, P., Berkowitz, P., Madden, V. J., and Rubenstein, D. S. (2006) Stabilization of plakoglobin and enhanced keratinocyte cell-cell adhesion by intracellular O-glycosylation. J. Biol. Chem. 281, 12786-12791
59. Han, I., and Kudlow, J. E. (1997) Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17, 2550-2558
60. Kim, H. S., Woo, J. S., Joo, H. J., and Moon, W. K. (2012) Cardiac transcription factor Nkx2.5 is downregulated under excessive OGlcNAcylation condition. PLoS One 7, e38053
61. Lafontaine-Lacasse, M., Dore, G., and Picard, F. (2011) Hexosamines stimulate apoptosis by altering SIRT1 action and levels in rodent pancreatic beta-cells. J. Endocrinol. 208, 41-49
62. Weake, V. M., and Workman, J. L. (2008) Histone ubiquitination: triggering gene activity. Mol. Cell 29, 653-663
63. Sakabe, K., Wang, Z., and Hart, G. W. (2010) Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc. Natl. Acad. Sci. U.S.A. 107, 19915-19920
64. Fujiki, R., Hashiba, W., Sekine, H., Yokoyama, A., Chikanishi, T., Ito, S., Imai, Y., Kim, J., He, H. H., Igarashi, K., Kanno, J., Ohtake, F., Kitagawa, H., Roeder, R. G., Brown, M., and Kato, S. (2011) GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature 480, 557-560
65. Zhang, S., Roche, K., Nasheuer, H. P., and Lowndes, N. F. (2011) Modification of histones by sugar beta-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycleregulated. J. Biol. Chem. 286, 37483-37495
66. Fong, J. J., Nguyen, B. L., Bridger, R., Medrano, E. E., Wells, L., Pan, S., and Sifers, R. N. (2012) beta-N-acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3. J. Biol. Chem. 287, 12195-12203
67. Chen, Q., Chen, Y., Bian, C., Fujiki, R., and Yu, X. (2013) TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493, 561-564
68. Guinez, C., Mir, A. M., Dehennaut, V., Cacan, R., Harduin-Lepers, A., Michalski, J. C., and Lefebvre, T. (2008) Protein ubiquitination is modulated by O-GlcNAc glycosylation. FASEB J. 22, 2901-2911
69. Sumegi, M., Hunyadi-Gulyas, E., Medzihradszky, K. F., and Udvardy, A. (2003) 26S proteasome subunits are O-linked N-acetylglucosaminemodified in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 312, 1284-1289
70. Zhang, F., Su, K., Yang, X., Bowe, D. B., Paterson, A. J., and Kudlow, J. E. (2003) O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115, 715-725
71. Keembiyehetty, C. N., Krzeslak, A., Love, D. C., and Hanover, J. A. (2011) A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasome. J. Cell Sci. 124, 2851-2860
72. Zhang, F., Paterson, A. J., Huang, P., Wang, K., and Kudlow, J. E. (2007) Metabolic control of proteasome function. Physiology (Bethesda) 22, 373-379
73. Ruan, H. B., Singh, J. P., Li, M. D., Wu, J., and Yang, X. (2013) Cracking the O-GlcNAc code in metabolism. Trends Endocrinol. Metab. 24, 301-309
74. Deng, H. X., Chen, W., Hong, S. T., Boycott, K. M., Gorrie, G. H., Siddique, N., Yang, Y., Fecto, F., Shi, Y., Zhai, H., Jiang, H., Hirano, M., Rampersaud, E., Jansen, G. H., Donkervoort, S., Bigio, E. H., Brooks, B. R., Ajroud, K., Sufit, R. L., Haines, J. L., Mugnaini, E., Pericak-Vance, M. A., and Siddique, T. (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211-215
75. Huang, Q., and Figueiredo-Pereira, M. E. (2010) Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis 15, 1292-1311
76. Dennissen, F. J., Kholod, N., and van Leeuwen, F. W. (2012) The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim? Prog. Neurobiol. 96, 190-207
77. Gong, B., Kielar, C., and Morton, A. J. (2012) Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation. PLoS One 7, e41450
78. Gong, C. X., Liu, F., and Iqbal, K. (2012) O-GlcNAc cycling modulates neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 109, 17319-17320
79. Shan, X., Vocadlo, D. J., and Krieger, C. (2012) Reduced protein O-glycosylation in the nervous system of the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Neurosci. Lett. 516, 296-301
80. Yuzwa, S. A., Shan, X., Macauley, M. S., Clark, T., Skorobogatko, Y., Vosseller, K., and Vocadlo, D. J. (2012) Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat. Chem. Biol. 8, 393-399
81. Wang, P., Lazarus, B. D., Forsythe, M. E., Love, D. C., Krause, M. W., and Hanover, J. A. (2012) O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases. Proc. Natl. Acad. Sci. U.S.A. 109, 17669-17674
82. Fulda, S., Rajalingam, K., and Dikic, I. (2012) Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications. EMBO Mol. Med. 4, 545-556
83. Dey, A., Seshasayee, D., Noubade, R., French, D. M., Liu, J., Chaurushiya, M. S., Kirkpatrick, D. S., Pham, V. C., Lill, J. R., Bakalarski, C. E., Wu, J., Phu, L., Katavolos, P., LaFave, L. M., Abdel-Wahab, O., Modrusan, Z., Seshagiri, S., Dong, K., Lin, Z., Balazs, M., Suriben, R., Newton, K., Hymowitz, S., Garcia-Manero, G., Martin, F., Levine, R. L., and Dixit, V. M. (2012) Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337, 1541-1546
84. Slawson, C., and Hart, G. W. (2011) O-GlcNAc signalling: implications for cancer cell biology. Nat. Rev. Cancer 11, 678-684
85. Li, W., Bengtson, M. H., Ulbrich, A., Matsuda, A., Reddy, V. A., Orth, A., Chanda, S. K., Batalov, S., and Joazeiro, C. A. (2008) Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS One 3, e1487
86. Nijman, S. M., Luna-Vargas, M. P., Velds, A., Brummelkamp, T. R., Dirac, A. M., Sixma, T. K., and Bernards, R. (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786
87. Drougat, L., Olivier-Van Stichelen, S., Mortuaire, M., Foulquier, F., Lacoste, A. S., Michalski, J. C., Lefebvre, T., and Vercoutter-Edouart, A. S. (2012) Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition. Biochim. Biophys. Acta 1820, 1839-1848
88. Sprung, R., Nandi, A., Chen, Y., Kim, S. C., Barma, D., Falck, J. R., and Zhao, Y. (2005) Tagging-via-substrate strategy for probing O-GlcNAc modified proteins. J. Proteome Res. 4, 950-957
89. Hahne, H., Sobotzki, N., Nyberg, T., Helm, D., Borodkin, V. S., van Aalten, D. M., Agnew, B., and Kuster, B. (2013) Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry. J. Proteome Res. 12, 927-936
90. Trinidad, J. C., Barkan, D. T., Gulledge, B. F., Thalhammer, A., Sali, A., Schoepfer, R., and Burlingame, A. L. (2012) Global identification and characterization of both O-GlcNAcylation andphosphorylation at the murine synapse. Mol. Cell. Proteomics 11, 215-229
91. Alfaro, J. F., Gong, C. X., Monroe, M. E., Aldrich, J. T., Clauss, T. R., Purvine, S. O., Wang, Z., Camp, D. G., 2nd, Shabanowitz, J., Stanley, P., Hart, G. W., Hunt, D. F., Yang, F., and Smith, R. D. (2012) Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Proc. Natl. Acad. Sci. U.S.A. 109, 7280-7285
92. Clark, P. M., Dweck, J. F., Mason, D. E., Hart, C. R., Buck, S. B., Peters, E. C., Agnew, B. J., and Hsieh-Wilson, L. C. (2008) Direct in-gel fluorescence detection and cellular imaging of O-GlcNAc-modified proteins. J. Am. Chem. Soc. 130, 11576-11577
93. Lefebvre, T., Pinte, S., Guerardel, C., Deltour, S., Martin-Soudant, N., Slomianny, M. C., Michalski, J. C., and Leprince, D. (2004) The tumor suppressor HIC1 (hypermethylated in cancer 1) is O-GlcNAc glycosylated. Eur. J. Biochem. 271, 3843-3854
94. Zaro, B. W., Yang, Y. Y., Hang, H. C., and Pratt, M. R. (2011) Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1. Proc. Natl. Acad. Sci. U.S.A. 108, 8146-8151
95. Hahne, H., Moghaddas Gholami, A., and Kuster, B. (2012) Discovery of O-GlcNAc-modified proteins in published large-scale proteome data. Mol. Cell. Proteomics 11, 843-850
96. Teo, C. F., Ingale, S., Wolfert, M. A., Elsayed, G. A., Not, L. G., Chatham, J. C., Wells, L., and Boons, G. J. (2010) Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc. Nat. Chem. Biol. 6, 338-343
97. Nandi, A., Sprung, R., Barma, D. K., Zhao, Y., Kim, S. C., Falck, J. R., and Zhao, Y. (2006) Global identification of O-GlcNAc-modified proteins. Anal. Chem. 78, 452-458